Norgine Limited

Norgine House, Widewater Place, Moorhall Road, Harefield, Middlesex, UB9 6NS
Telephone: +44 (0)1895 826 600
Fax: +44 (0)1895 825 865
E-mail:
Medical Information e-mail: medinfo@norgine.com

Patient Information Leaflet last updated on the eMC: 30/11/2010
PIL MOVICOL 13.8g sachet, powder for oral solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 30/11/2010 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 22/04/2010 and displayed until 30/11/2010
Reasons for adding or updating:
  • Extra statutory information
Updated on 11/03/2010 and displayed until 22/04/2010
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
Updated on 30/05/2008 and displayed until 11/03/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 17/08/2007 and displayed until 30/05/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 15/06/2007 and displayed until 17/08/2007
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 17/01/2005 and displayed until 15/06/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 13/01/2005 and displayed until 17/01/2005
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 17/09/2004 and displayed until 13/01/2005
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 17/09/2004 and displayed until 17/09/2004
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   potassium chloride
   sodium chloride
   sodium bicarbonate
   macrogol 3350